The Medical Cyclotron Market has gained significant momentum in recent years, driven by the increasing demand for positron emission tomography (PET) imaging, radiopharmaceutical production, and cancer diagnostics. Cyclotrons, as particle accelerators, play a crucial role in producing short-lived isotopes used in medical imaging and therapy. The market's expansion is further supported...

The global live cell imaging market size was estimated at USD 2.48 billion in 2023 and is projected to reach USD 4.49 billion by 2030, growing at a CAGR of 8.9% from 2024 to 2030. The growth of this market is primarily driven by continuous technological advancements, the increasing prevalence of chronic diseases, and the rising demand for personalized medicine. One of the key driving...

"Executive Summary Live Cell Imaging Market : CAGR Value Global live cell imaging market size was valued at USD 4.59 billion in 2024 and is projected to reach USD 10.13 billion by 2032, with a CAGR of 10.40% during the forecast period of 2025 to 2032. The analysis and estimations conducted via the winning Live Cell Imaging Market report help to get an idea about the product...

In-Depth Study of Oncology Nutrition Market: Global Industry Outlook, Pipeline Overview of the Oncology Nutrition Market The global Oncology Nutrition Market is witnessing significant growth, driven by the increasing prevalence of cancer and the rising demand for nutritional support as a critical component of cancer care. Oncology nutrition encompasses dietary interventions, medical...

In-Depth Study of Oncology Nutrition Market: Global Industry Outlook, Pipeline Overview of the Oncology Nutrition Market The global Oncology Nutrition Market is witnessing significant growth, driven by the increasing prevalence of cancer and the rising demand for nutritional support as a critical component of cancer care. Oncology nutrition encompasses dietary interventions, medical...

The global synthetic biology market size is expected to reach USD 55.37 billion by 2030, registering a CAGR of 18.97% during the forecast period, according to a new report by Grand View Research, Inc. The presence of government and private funding to support research in vaccines and a strong synthetic biologic-based product pipeline in clinical trials are the key driving factors for the...